The fact that riluzole upregulates the expression of activin B could potentially have a negative impact on riluzole response since activin is suggested to play an active role in several carcinomas and glioma migration, invasion and progression [53], [54], [55], [56], [57]. This evidence concerns the gene INHBE and central nervous system cancer.